Clinical Assessment: Asymptomatic Severe Hypertension (BP 200/100 mmHg, Treatment-Naive)

Step 1 - Rule Out a Hypertensive Emergency (Do This First)

• Chest pain, back pain (aortic dissection)
• Dyspnoea, orthopnoea (acute pulmonary oedema/LVF)
• Headache, visual disturbance, confusion (hypertensive encephalopathy)
• Decreased urine output (AKI)
• Focal neurological deficits (haemorrhagic stroke)

• Fundoscopy - papilloedema, haemorrhages, exudates
• Auscultation - S3, S4, pulmonary crepitations
• Peripheral pulses (asymmetry suggests dissection)
• Neurological screen

• Serum creatinine + electrolytes (renal function/hypokalaemia suggesting secondary HTN)
• Urine dipstick (proteinuria, haematuria = renal TOD)
• ECG (LVH, ischaemia)
• Note: In truly asymptomatic patients, abnormal results attributable to acute hypertensive injury are found in <6% of cases, so extensive testing is not mandatory - Tintinalli's Emergency Medicine

Step 2 - Should You Start Antihypertensives?

• Is 50 years old
• Has known hypertension for at least 2 weeks at 200/100
• Has NEVER been on treatment
• Is at very high risk for stroke, ACS, renal damage, and heart failure if untreated

"Uncorrected hypertension is associated with an eventual increased risk of cardiovascular events and renal dysfunction... These considerations support initiating outpatient blood pressure reduction regimens." - Tintinalli's Emergency Medicine

"Initiation of antihypertensive therapy with long-acting agents (if patients are treatment naive)... the most important aspect is ensuring adequate follow-up, generally within 1 week." - Comprehensive Clinical Nephrology, 7th ed.

Step 3 - How to Lower the BP (The "How" is Critical)

Step 4 - First-Line Drug Choice (Treatment-Naive Patient)

Step 5 - Screen for Secondary Causes

• Renal artery stenosis (check creatinine after starting ACEI/ARB)
• Primary aldosteronism (serum aldosterone:renin ratio if hypokalaemia)
• Sleep apnoea history
• Medication review (NSAIDs, decongestants, OCP)

Step 6 - Follow-Up Plan

Bottom Line

Amlodipine 5mg + Telmisartan 40mg - Is It a Good Starting Point?

Why This Combination Makes Pharmacological Sense

What the Evidence Shows Specifically for This Dose Pair

• Telmisartan 40mg + Amlodipine 5mg produced significantly greater BP reductions than either monotherapy alone
• BP control rates were substantially higher with combination vs monotherapy
• Peripheral oedema (amlodipine's main side effect) was reduced when telmisartan was added - because ARBs counteract the CCB-induced capillary leakage

"Combination therapy with 40mg telmisartan and 5mg amlodipine significantly decreased 24-hour mean BP and clinical BP in patients whose hypertension was uncontrolled by 5mg amlodipine alone." - Hypertension Research, 2013

Is Combination Therapy Appropriate From the Start Here?

One Caution Before Starting

• Check creatinine and potassium before starting (or within 1-2 weeks after)
• If creatinine rises >30% after starting telmisartan, consider renal artery stenosis and hold the ARB
• Telmisartan is contraindicated in pregnancy - confirm this is not relevant here
• If the patient is volume-depleted (unlikely given the BP level, but worth asking about diuretics, vomiting, etc.), correct this first as ARBs can cause first-dose hypotension

Titration Pathway

• Week 1-2 review: Check BP response, renal function, potassium, and tolerability
• If BP still >160/100 at 4 weeks: Uptitrate to Telmisartan 80mg + Amlodipine 5mg (T80/A5)
• If still not at target at 8-12 weeks: Add a third agent - a thiazide-like diuretic (chlorthalidone 12.5-25mg or indapamide 1.5mg SR). Notably, a 2024 Lancet RCT showed telmisartan + amlodipine + indapamide as a low-dose triple pill was more effective than dual combinations with an excellent safety profile (PMID 39426836)

Summary

• Pharmacologically rational (complementary mechanisms)
• Evidence-backed at this specific dose pair
• Guideline-endorsed as initial combination therapy when BP is significantly above target
• Practical (once daily, available as a single-pill combination in most markets)
• Well-tolerated with a low side-effect burden

Is Amlodipine + Telmisartan the "Best" Combination?

The Four First-Line Classes (All Guidelines Agree)

How to Choose: Comorbidities Drive Everything

So Where Does Amlodipine + Telmisartan Sit?

• ARB + CCB is the combination with the strongest outcome data (the ONTARGET, VALUE, and multiple other trials)
• Telmisartan has the longest half-life of all ARBs - best 24-hour BP coverage
• ARB eliminates the CCB-induced ankle oedema (the most common reason people stop amlodipine)
• No cough (unlike ACE inhibitors - affects up to 15% of patients, and up to 30-40% in South/East Asian populations)
• Available as a single-pill combination
• Once daily - excellent for adherence

1. ACE inhibitor instead of ARB - if you prefer ramipril/perindopril (also excellent, but carry a cough risk; classically preferred post-MI or in heart failure)
2. Add a thiazide-like diuretic instead of or in addition to one of the above - if BP remains uncontrolled, or if the patient has oedema
3. ACE/ARB + CCB + Thiazide (triple pill) - emerging evidence from the 2024 Lancet trial (PMID 39426836) shows telmisartan + amlodipine + indapamide as a low-dose triple pill outperforms dual therapy and is very well tolerated. This may actually be a better starting point given a BP of 200/100

One Key Question You Haven't Told Me

• If yes - Amlodipine + Telmisartan remains excellent (ARB is actually more important here)
• If he has heart failure or coronary disease - switch from ARB to ACE inhibitor, and add a beta-blocker
• If he is of African descent - a CCB + thiazide combination may be more effective than ARB-based therapy as ARBs have reduced monotherapy efficacy in this population

Bottom Line

Telmisartan 40 + HCTZ 12.5 vs Telmisartan 40 + Amlodipine 5 - Head to Head

The ACCOMPLISH Trial - The Most Important Evidence

• 11,506 high-risk hypertensive patients randomised to either:
  • ACE inhibitor + Amlodipine vs ACE inhibitor + HCTZ 12.5mg
• Result: Despite achieving nearly identical BP numbers, the ACE inhibitor + Amlodipine group had:
  • 20% fewer cardiovascular events (HR 0.80)
  • Significantly fewer fatal/non-fatal MIs
  • Better renal outcomes - doubling of creatinine and end-stage renal disease were more frequent in the HCTZ group

"Despite similar blood pressure reductions, benazepril + amlodipine was superior to benazepril + HCTZ for cardiovascular outcomes." - ACCOMPLISH trial, NEJM 2008

Direct Telmisartan Comparison (TAT-Kobe Study, PMID 26719915)

HCTZ 12.5mg - The Specific Problem With This Dose

Where Telmisartan + HCTZ IS a Reasonable Choice

• Patient with volume overload / oedema - diuretic component directly helpful
• Salt-sensitive hypertension (common in older patients, Black patients)
• Budget-constrained settings where HCTZ combinations are cheaper
• As a stepping stone - many patients end up on all three classes anyway (ARB + CCB + diuretic)

Practical Summary

My Recommendation for This Patient

1. Increase Telmisartan to 80mg
2. Then add indapamide 1.5mg SR (not HCTZ) as a third agent - this is the most evidence-backed triple combination available today (2024 Lancet RCT, PMID 39426836)

Yes - Separate Tablets Are Fine. Now, Timing:

The Circadian Problem You Are Trying to Solve

• Lowest during sleep (2-3 AM)
• Sharp rise starting at 6 AM ("morning surge") - this is when strokes and MIs cluster
• Peak around 10 AM - 12 PM
• Gradual fall through the evening

The Three Key Trials on Timing

• Morning vs evening dosing of antihypertensives
• Primary outcome (MI, stroke, vascular death): NO difference (3.7% morning vs 3.4% evening, p=0.53)
• Conclusion: Cardiovascular outcomes are the same regardless of timing
• Patient can take at whichever time improves their adherence

• Bedtime dosing provided 3.0 mmHg greater reduction in nighttime systolic BP vs morning
• Better circadian rhythm restoration
• No increase in nocturnal hypotension risk
• Conclusion: Bedtime dosing has a modest but real advantage for nocturnal BP control

• Even though telmisartan has a half-life >24 hours, bedtime dosing still lowered sleep-time BP more effectively than morning dosing in a study of 215 patients
• Morning BP surge was equally controlled either way (due to its long half-life)

Practical Timing Recommendation for This Patient

The Most Practical Answer

• Many patients find morning routines easier to remember
• Adherence matters far more than timing
• Amlodipine in particular has a very flat plasma profile due to its extremely long half-life (~35-50 hours) - timing has minimal impact on its 24-hour effect

Bottom Line

Take both tablets together in the morning, same time daily. Review with ambulatory BP monitoring at 4-6 weeks. If he is a non-dipper, shift dosing to bedtime.

Approach to Recurrent Epigastric Pain - 32M, Normal ECG/Troponin/USG, Responds to PPI but Recurs

Step 1 - First, Complete Your History (Critical - You Haven't Told Me These)

Step 2 - Classify: Are There Alarm Features?

• Unintentional weight loss
• Dysphagia or odynophagia
• Persistent vomiting
• Melaena / haematemesis / iron-deficiency anaemia
• Palpable abdominal mass
• Family history of upper GI malignancy
• Age >55-60 years at first presentation

Step 3 - The Recommended Management Strategy (Guideline-Based)

"Test and Treat" for H. pylori - THIS Is Your Next Step

"In areas of high H. pylori prevalence (>20%) and in the absence of red flags, screening for and eradication of infection is usually the next step." - Yamada's Textbook of Gastroenterology, 7th ed.

"Most recent North American guidelines suggest a trial of PPI in the absence of alarm features and H. pylori - and do not recommend endoscopy to investigate dyspepsia in patients under age 60." - Yamada's Textbook of Gastroenterology, 7th ed.

Step 4 - If H. pylori Positive: Eradicate

• Pantoprazole 40mg BD + Amoxicillin 1g BD + Clarithromycin 500mg BD x 14 days
• Confirm eradication with UBT or stool antigen at least 4 weeks after completing treatment (not serology)
• If eradication successful and symptoms resolve - no further investigation needed

• Bismuth subcitrate + Metronidazole + Tetracycline + PPI x 14 days

Step 5 - If H. pylori Negative (or Symptoms Persist After Eradication)

• To rule out peptic ulcer disease, erosive gastritis, oesophagitis, or rarely early gastric malignancy
• Endoscopy before treatment is still the gold standard but is reserved for this step in a young patient without alarm features

Step 6 - Treatment of Functional Dyspepsia (Stepwise)

The Key Point Here

Stop pantoprazole for 2 weeks, then do a Urea Breath Test or H. pylori Stool Antigen.

Integrating the History - What This Tells You

• No NSAIDs - removes drug-induced ulcer
• No alarm features (no weight loss, no melaena, no vomiting, no dysphagia)
• No IBS overlap (no loose stools)
• No functional/psychosomatic drivers (no stress, sleep fine)
• Smoking + weekly alcohol - both are positive risk factors
• Age 32, responds to PPI, recurs off PPI

Most Likely Diagnosis: H. pylori-Associated Peptic Ulcer Disease or Gastritis

"Cigarette smoking doubles the risk for PUD; it delays healing and promotes recurrence." - Washington Manual of Medical Therapeutics

"Direct cellular damage contributes to gastritis induced by alcohol consumption." - Robbins Pathology

Your Action Plan - Streamlined for This Patient

Immediate Step: Stop PPI and Test for H. pylori

If H. pylori Positive (High probability given risk profile):

Lifestyle Advice to Give Simultaneously - Non-Negotiable

If H. pylori Negative:

• Erosive gastritis
• Peptic ulcer (H. pylori-negative idiopathic ulcer - rare but exists, especially with smoking + alcohol)
• Oesophagitis / Barrett's
• Rarely - submucosal lesion

Summary Flowchart for This Patient

32M, epigastric pain, PPI-responsive but recurrent
No NSAIDs, no alarm features, smoker, weekly alcohol
↓
STOP PPI x 2 weeks
↓
Urea Breath Test (UBT) or H. pylori Stool Antigen
↓
POSITIVE → 14-day triple therapy → confirm eradication at 4 weeks
                                  → symptoms resolved = no further investigation needed
NEGATIVE → OGD (upper GI endoscopy)
         → If OGD normal → Functional Dyspepsia diagnosis
                         → PPI trial ± prokinetic, counsel on smoking/alcohol

Can You Give Empirical Triple Therapy Without Testing?

The Traditional Argument FOR Empirical Treatment (Why Clinicians Did This)

• Young patient (<55 years)
• No alarm features
• Recurrent dyspepsia
• Resource-limited settings where UBT is not easily accessible

The 2024 ACG Guideline - The Critical Update You Need to Know

Clarithromycin triple therapy (PPI + Amoxicillin + Clarithromycin) is NO longer recommended as first-line empirical therapy - because clarithromycin resistance has crossed the threshold making it unacceptable.

• Clarithromycin resistance rates are now >30% in the US, and rising globally
• At >15-20% resistance, clarithromycin triple therapy eradication rates fall below 80% - which is the minimum acceptable threshold
• Giving clarithromycin empirically in an area with high resistance means you may fail eradication, select for resistant strains, and leave the patient worse off

What Applies to Your Specific Context

The Bigger Problem With Going Empirical: You Cannot Confirm Eradication

• You cannot confirm whether H. pylori was even present
• You cannot confirm it was eradicated (because you have no baseline)
• If symptoms recur, you are stuck - did treatment fail? Was it never H. pylori in the first place?
• You have already used clarithromycin, making second-line therapy harder

1. Confirm H. pylori is actually present before treating
2. Do a post-treatment UBT to confirm eradication
3. Know with certainty whether the condition is cured

Practical Middle Ground - What Most Clinicians Actually Do

My Direct Recommendation for This Patient

1. Stop pantoprazole now for 2 weeks
2. Send UBT or stool antigen
3. If positive - treat with appropriate regimen based on local resistance patterns
4. Confirm eradication at 4 weeks post-treatment

Pantop HP Kit - Can You Give It?

What's in the Pantop HP Kit

The Honest Assessment

• 7-day triple therapy eradication: ~70-75%
• 14-day triple therapy eradication: ~80-85%
• You need TWO strips (14 days total) to meet the recommended duration

What to Do Practically

• Give 2 kits = 14 days of treatment (not just one 7-day strip)
• Take both tablets of the kit before meals, twice daily
• Counsel on completing the full course even if symptoms improve - partial treatment is worse than no treatment (selects resistance)
• After 4 weeks of completing treatment, do a stool antigen test or UBT to confirm eradication
• Tell the patient to stop smoking and alcohol during and after treatment - both impair mucosal healing and increase recurrence

Side Effects to Warn the Patient About

• Metallic/bitter taste (clarithromycin) - very common, harmless
• Loose stools / diarrhoea - transient, take probiotic alongside (Lactobacillus)
• Nausea - take with food if it becomes troublesome
• No alcohol during the course - interacts with metronidazole if ever used, and worsens gastric inflammation

If It Fails (Symptoms Return After 14 Days + Confirmed H. pylori Still Positive)

• Pantoprazole 40mg BD + Bismuth subcitrate 120mg QDS + Metronidazole 400mg TDS + Tetracycline 500mg QDS x 14 days

Bottom Line

Yes, give 2 x Pantop HP kits (14 days total), not just one strip. Warn about side effects. Add a probiotic. Reinforce stopping smoking and alcohol. Check cure with stool antigen 4 weeks after finishing.

50-Year-Old Woman, Severe Muscle Cramps, HTN on Amlodipine 5mg, Not Responding to Myoril + Dynapar

Step 1 - Ask These Questions RIGHT NOW Before Anything Else

Step 2 - Do These Bedside Clinical Tests Immediately

"The archetypical presentation of hypocalcemia is tetany, classically diagnosed by the Chvostek sign or the Trousseau sign (carpal spasm following inflation of an arm tourniquet above systolic BP for 3 min)." - Morgan & Mikhail's Clinical Anaesthesiology

• Pulse - any irregularity (hypokalaemia, hypocalcaemia both cause arrhythmias)
• Deep tendon reflexes - hyperreflexia in hypocalcaemia, hyporeflexia in hypokalaemia/hypomagnesaemia

Step 3 - Send These Blood Tests Urgently

Step 4 - The Most Likely Diagnoses in This Patient (Ranked)

• Hypokalaemia - most common cause of severe muscle cramps in a hypertensive patient. She may be taking a diuretic you don't know about, or have secondary hyperaldosteronism. Even without a diuretic, many hypertensive patients have low potassium.
• Hypocalcaemia - 50-year-old woman is likely peri/post-menopausal. Vitamin D deficiency + calcium deficiency is extremely prevalent in this demographic in South Asia. This is a very strong possibility.
• Hypomagnesaemia - magnesium deficiency is the most under-diagnosed electrolyte problem. It causes cramps that don't respond to anything else because low Mg2+ also prevents correction of Ca2+ and K+.

Step 5 - Immediate Treatment Based on Clinical Findings

• Dilute in 100ml NS or 5% Dextrose
• Monitor HR and BP during infusion
• Can repeat if symptoms persist
• Follow with oral calcium + vitamin D supplementation

• Mild (3.0-3.5): Oral potassium chloride (Slow K / Syrup KCl) + banana/coconut water
• Moderate (2.5-3.0): IV potassium chloride via infusion (never IV bolus - fatal)
• Always check Mg2+ alongside - you cannot correct K+ without correcting Mg2+

• IV Magnesium sulphate 2g in 100ml NS over 20 minutes
• Magnesium must be corrected before calcium and potassium will respond to treatment

Step 6 - Why Myoril + Dynapar Didn't Work

• Musculoskeletal spasm from mechanical causes
• Nociceptive pain / inflammation

• Electrolyte-driven muscle cramps (the nerve-muscle excitation threshold is low due to ion imbalance - no drug relaxant fixes this)
• Metabolic causes (hypothyroid, vitamin D deficiency)
• Statin myopathy

Bottom Line Action Plan

50F, severe cramps, on Amlodipine, not responding to Myoril/Dynapar
↓
1. Bedside: Chvostek sign + Trousseau sign NOW
2. Ask about statins, diuretics, diet, menopause
3. Send: Serum electrolytes (K+, Ca2+, Mg2+, Na+, PO4), Albumin, RFT, TFT, CPK, ECG
↓
Chvostek/Trousseau +ve → IV Calcium Gluconate 10ml slow IV immediately
K+ low → Oral/IV KCl (check Mg2+ first)
Mg2+ low → IV MgSO4 2g over 20 min
CPK elevated → Stop statin if on one
TSH high → Treat hypothyroidism
Vit D low → Cholecalciferol 60,000 IU weekly x 8-12 weeks + Calcium supplementation

This Is Vitamin D Deficiency Myopathy - And Here Is Why Calcium Was Normal

Why Is Calcium Normal Despite Low Vitamin D?

When vitamin D falls, calcium absorption from the gut decreases → the parathyroid glands sense this and PTH rises → PTH mobilises calcium from bones to keep serum calcium normal → so serum calcium remains "normal" at the cost of bone demineralisation

• Proximal muscle weakness
• Severe muscle cramps
• Difficulty walking - exactly what this patient has

Why Myoril and Dynapar Didn't Work

Treatment Plan

Immediate (Today)

• Serum potassium and magnesium (still worth checking - can co-exist with vit D deficiency)
• PTH if available (will likely be elevated - confirms the mechanism)

Vitamin D Replacement - Loading Dose Regimen

Cholecalciferol 60,000 IU (1 sachet/capsule) once weekly x 8 weeks

Add Calcium Supplementation Alongside

• Calcium carbonate 500mg + Vitamin D3 250 IU - one tablet twice daily with food
• OR dietary advice: dairy, ragi, sesame seeds, green leafy vegetables

Maintenance After Loading (After 8-12 weeks)

• Recheck Vitamin D level at 3 months
• If replete (>30 ng/mL): Switch to cholecalciferol 1,500-2,000 IU daily as maintenance
• Ongoing maintenance is lifelong in most Indian women given low sun exposure, dietary habits

When Will She Feel Better?

• Muscle cramps typically improve within 2-4 weeks of starting treatment
• Full resolution of weakness and ability to walk normally: 4-8 weeks
• Do NOT expect overnight improvement - this is a metabolic deficiency that took months to develop and takes weeks to correct
• Do NOT give diclofenac or muscle relaxants repeatedly - they are not only ineffective but NSAIDs can also interfere with Vitamin D metabolism slightly

One More Thing - Her Amlodipine

Summary

7-Year-Old Boy, Acute Left Knee Monoarthritis - A Critical Review of Your Approach

The Core Problem With the Initial Approach

• Does NOT treat septic arthritis adequately (amoxiclav is not first-line for septic arthritis)
• If it partially suppresses a septic joint, it reduces the yield of synovial fluid culture from 80% to 38%
• It may mask the diagnosis and delay definitive treatment
• It is not indicated for reactive arthritis or JIA

The Most Important Question You Must Ask First

Is this SEPTIC ARTHRITIS until proven otherwise?

• Avascular necrosis of the femoral head
• Permanent joint destruction
• Osteomyelitis
• Sepsis and death

The History You Must Have Taken Immediately

The Kocher Criteria - Your Risk Stratification Tool

"When all 5 markers are negative, patients have less than 1% chance of septic arthritis." - Rosen's Emergency Medicine

The Correct Investigation Approach

• CBC with differential (WBC)
• ESR
• CRP (most sensitive for septic arthritis)
• Blood culture (before any antibiotic)
• ASO titre (Antistreptolysin O) - for ARF/post-streptococcal reactive arthritis
• Anti-DNase B
• Throat swab culture

• X-ray knee - good (to rule out fracture, bony lesion, joint space widening)
• Ultrasound knee - better than X-ray for detecting joint effusion; also guides aspiration
• If hip pain referred to knee suspected - X-ray hip + USS hip

The Differential Diagnosis - Ranked for This Child

About the Prednisolone - Why You Were Right Not to Give It

1. If this was septic arthritis - steroids would suppress fever and inflammatory markers, masking a life-threatening joint infection, suppressing the immune response, and allowing the organism to destroy the joint
2. If this was JIA - steroids are not first-line; NSAIDs are used first
3. If this was leukaemia (which can present as joint pain/swelling) - steroids could cause tumour lysis or temporarily improve symptoms, delaying diagnosis
4. If this was ARF - aspirin/NSAIDs are the treatment, not steroids (unless there is carditis)

Steroids in an undiagnosed acute monoarthritis in a child = potentially dangerous. You were absolutely right to hold them.

What Should Have Happened - Step by Step

7-year-old boy, acute left knee monoarthritis, 2 days
↓
STEP 1: Full history - fever? weight-bearing? recent infection?
↓
STEP 2: Full examination - temperature, ability to walk, joint exam,
         skin (rash), eyes, lymph nodes, heart murmur (ARF)
↓
STEP 3: Apply Kocher criteria - calculate risk of septic arthritis
↓
STEP 4: Investigations - CBC, ESR, CRP, blood culture, ASO titre, X-ray knee, USS knee
↓
Kocher score HIGH (≥2 criteria) or cannot weight-bear + fever
→ DO NOT start antibiotics until blood culture taken
→ URGENT referral to orthopaedics / paediatrics
→ Joint aspiration (arthrocentesis) - send fluid for MC&S, cell count
→ If septic arthritis confirmed: IV antibiotics + surgical washout (arthrotomy/arthroscopy)
↓
Kocher score LOW + weight-bearing + afebrile + ASO positive
→ Consider reactive arthritis / ARF
→ NSAIDs (ibuprofen) + throat swab + penicillin if strep confirmed
→ Paediatric rheumatology referral
↓
CBC shows blast cells / anaemia / thrombocytopenia
→ URGENT paediatric oncology - rule out leukaemia

About Amoxiclav Specifically

• IV Flucloxacillin (or IV cloxacillin) 50mg/kg/dose 4-6 hourly - covers staph
• If MRSA suspected: IV vancomycin
• Given intravenously and after joint aspiration / blood culture
• Duration guided by culture and clinical response (minimum 3-4 weeks)

Summary Table - What You Did vs What Was Indicated

Updated Clinical Picture - Afebrile Child, No Infection, No Trauma, No Family History

Revised Differential - Top Diagnoses for an Afebrile 7-Year-Old With Knee Monoarthritis

The Diagnosis That Must Not Be Missed: Leukaemia

A child with joint pain/swelling and NO fever, NO infection, NO trauma must have leukaemia excluded.

• Monoarthritis or oligoarthritis
• Bone/joint pain (often worse at night)
• Completely afebrile initially
• Normal or near-normal CBC early on (blast cells may not yet be overwhelming)

• Night pain waking him from sleep? (leukaemia pain is typically worse at night)
• Fatigue, pallor, looking unwell in general?
• Easy bruising, petechiae, nosebleeds?
• Lymph node swelling anywhere?

• Haemoglobin - anaemia?
• Platelet count - thrombocytopenia?
• WBC - elevated blasts? Lymphocytosis?
• If blast cells present on peripheral smear - urgent oncology referral same day

What the CBC and X-Ray Tell You

Additional Investigations Now Required

The Single Most Important Referral

1. Full workup as above
2. Slit lamp eye examination - if JIA is confirmed, especially ANA-positive oligoarticular JIA, there is a risk of asymptomatic chronic uveitis that causes silent blindness if not caught. The child will never complain of eye symptoms, which makes it even more dangerous.

Was Amoxiclav Appropriate Here?

• Had no indication for antibiotics at all
• Amoxiclav treats bacterial infections - there is no bacterial target here
• You were treating a symptom (swelling/redness) rather than a diagnosed infection
• Appropriate treatment while awaiting diagnosis is NSAIDs (ibuprofen you already gave) + rest + cold packs

Was Ibuprofen Appropriate?

• First-line symptomatic treatment for JIA, reactive arthritis, transient synovitis
• Anti-inflammatory + analgesic
• Safe in this age group at correct weight-based dosing

Revised Action Plan for This Boy

7-year-old boy, afebrile knee monoarthritis, no fever/trauma/infection
↓
CBC + blood film review → blasts? → urgent oncology if yes
↓
ESR, CRP, ANA, RF, ASO titre, LDH
↓
USS knee → confirms effusion
↓
X-ray review → periosteal reaction? → leukaemia/bone tumour
↓
Continue ibuprofen for pain/inflammation
STOP amoxiclav - no indication
NO prednisolone - correct decision
↓
Review CBC and bloods result
↓
Normal bloods + effusion only → Paediatric rheumatology referral
→ ANA positive → arrange slit lamp eye exam urgently
→ Diagnosis likely oligoarticular JIA or reactive arthritis
↓
Abnormal CBC (low Hb/platelets/blasts) → URGENT paediatric oncology same day

Bottom Line